Source:http://linkedlifedata.com/resource/pubmed/id/11466334
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2001-7-23
|
pubmed:abstractText |
CD44 is a ubiquitous molecule known as a hyaluronan receptor. However, the relevance of CD44 to inflammatory processes, for example, rheumatoid synovitis, remains unclear. In this study, we propose a novel function for CD44 using synovial cells from rheumatoid arthritis (RA) patients and demonstrated that CD44 cross-linking augmented Fas expression and subsequent Fas-mediated apoptosis of the cells: 1) cross-linking of CD44 on RA synovial cells markedly augmented Fas expression and its mRNA transcription; 2) engagement of CD44 up-regulated Fas on the cells within 3 h, much more than IL-1beta and TNF-alpha did; 3) the Fas-mediated early apoptotic change of the cells was amplified by CD44 cross-linking; and 4) hyaluronan, especially when fragmented, also augmented Fas-mediated early apoptosis of the cells. Based on these findings, we postulate a new concept: that interaction of CD44 on RA synovial cells with hyaluronan fragments present in the surrounding extracellular matrix augments Fas expression as well as Fas-mediated apoptosis of synovial cells. This may lead to spontaneous growth arrest through Fas-Fas ligand pathway observed in synovial cells of RA synovitis in vivo.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adjuvants, Immunologic,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD44,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD95,
http://linkedlifedata.com/resource/pubmed/chemical/Hyaluronic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Ligands,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
167
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1198-203
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11466334-Adjuvants, Immunologic,
pubmed-meshheading:11466334-Antibodies, Monoclonal,
pubmed-meshheading:11466334-Antigens, CD44,
pubmed-meshheading:11466334-Antigens, CD95,
pubmed-meshheading:11466334-Apoptosis,
pubmed-meshheading:11466334-Arthritis, Rheumatoid,
pubmed-meshheading:11466334-Cells, Cultured,
pubmed-meshheading:11466334-Dose-Response Relationship, Immunologic,
pubmed-meshheading:11466334-Humans,
pubmed-meshheading:11466334-Hyaluronic Acid,
pubmed-meshheading:11466334-Ligands,
pubmed-meshheading:11466334-Molecular Weight,
pubmed-meshheading:11466334-RNA, Messenger,
pubmed-meshheading:11466334-Synovial Membrane,
pubmed-meshheading:11466334-Transcription, Genetic,
pubmed-meshheading:11466334-Up-Regulation
|
pubmed:year |
2001
|
pubmed:articleTitle |
CD44 is the physiological trigger of Fas up-regulation on rheumatoid synovial cells.
|
pubmed:affiliation |
First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|